Geneva, March 20 -- International Clinical Trials Registry received information related to the study (ChiCTR2600119609) titled 'Pharmacodynamic Effects of Empagliflozin in Patients with Diabetes and Cirrhotic Ascites' on Feb. 28.

Study Type: Interventional study

Study Design: Single arm

Primary Sponsor: Baoding People's Hospital

Condition: Cirrhotic Ascites

Recruitment Status: Not Recruiting

Phase: N/A

Date of First Enrollment: 2026-03-03

Target Sample Size: Interventin group:10;

Countries of Recruitment: China

To know more, visit https://www.chictr.org.cn/showproj.html?proj=300725

Published by HT Digital Content Services with permission from Health Daily Digest....